Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05055219 · ClinicalTrials.gov registry record
Conventional and Metabolomic Predictors of Prediabetes & Insulin Resistance
A clinical trial of PreDiabetes and Obesity, Childhood, sponsored by University of Michigan.
- Completed
- Registry status
- 772
- Enrollment target
- 1
- Study location
NCT05055219: Completed study of PreDiabetes and Obesity, Childhood, sponsored by University of Michigan.
NCT05055219 is a study of PreDiabetes and Obesity, Childhood that has completed, run by University of Michigan. The registered enrollment target is 772 participants, above the 696-participant average among 149 other PreDiabetes trials with a reported enrollment target (11% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05055219, a study of PreDiabetes and Obesity, Childhood, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 772 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the longitudinal test performance of an array of conventional biomarkers of glycemia, including Hemoglobin A1c (HbA1c), and novel metabolomic biomarkers for identifying progression of glucose tolerance (normal to prediabetes or prediabetes to diabetes) in an overweight and obese pediatric cohort.
Primary Outcome
Normal glucose tolerance, prediabetes, or diabetes
Conditions Studied
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 772 participants |
| Start Date | 2015-06 |
| Est. Completion | 2020-02-19 |
What the finished NCT05055219 record still lists
NCT05055219 is an observational study that tracks outcomes without assigning an intervention. The registered 772 participants enrollment target is mid-sized for trials with a published cap, above the 696-participant average among 149 other PreDiabetes trials with a reported enrollment target (11% higher).
The record links to 2 conditions, with PreDiabetes appearing as the primary indexed condition, and to 0 interventions.
NCT05055219 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT05055219 about?
NCT05055219 is a clinical study titled "Conventional and Metabolomic Predictors of Prediabetes & Insulin Resistance". The purpose of this study is to evaluate the longitudinal test performance of an array of conventional biomarkers of glycemia, including Hemoglobin A1c (HbA1c), and novel metabolomic biomarkers for identifying progression of glucose tolerance (normal to prediabetes or prediabetes to diabetes) in an ...
What is the current status of trial NCT05055219?
This trial is currently completed. The enrollment target is 772 participants. The study started on 2015-06. Estimated completion is 2020-02-19.
What conditions does trial NCT05055219 study?
This clinical trial studies the following conditions: PreDiabetes, Obesity, Childhood.
Who is sponsoring clinical trial NCT05055219?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05055219 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PreDiabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05055219's enrollment target sits among peer trials
772 14th of 149 higher than 136 of 149 other PreDiabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PreDiabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Role of Islet GLP-1 in the Pathogenesis of Prediabetes
RECRUITING · Phase 2
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Diabetes Clinical Decision Support
RECRUITING · NA
-
Glucose Variability and Cognition in Prediabetes
RECRUITING
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05977348 · 770 participants · NA
Increasing Food Literacy in Preschoolers to Reduce Obesity Risk
- NCT06376994 · 770 participants · Phase 3
Multi-Center Clean Air Randomized Controlled Trial in COPD
- NCT06824467 · 770 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
- NCT06907173 · 770 participants · Phase 3
Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia